Skip to main content
. 2023 May 27;8:220. doi: 10.1038/s41392-023-01439-y

Fig. 1.

Fig. 1

PTMs in metabolic diseases. An increasing number of people are suffering from metabolic diseases, such as fatty liver, diabetes, obesity, hyperlipidemia and atherosclerosis. The liver, pancreas, adipose tissue, blood vessels, and heart are the main affected organs. Numerous proteins and PTMs (such as phosphorylation, acetylation, methylation, ubiquitination, etc.) are involved in the normal biology of these organs and the whole body. Abnormal PTMs thus are involved in the progression of these metabolic diseases and can be therapeutically targeted. The figure is generated with BioRender (https://biorender.com)